ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Aclarion Inc

Aclarion Inc (ACON)

0.2906
-0.0038
(-1.29%)
Closed July 18 4:00PM
0.2991
0.0085
( 2.92% )
Pre Market: 7:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.2991
Bid
0.2891
Ask
0.30
Volume
100
0.00 Day's Range 0.00
0.2668 52 Week Range 11.504
Market Cap
Previous Close
0.2906
Open
-
Last Trade Time
06:05:01
Financial Volume
-
VWAP
-
Average Volume (3m)
606,991
Shares Outstanding
8,203,500
Dividend Yield
-
PE Ratio
-0.48
Earnings Per Share (EPS)
-0.6
Revenue
75k
Net Profit
-4.91M

About Aclarion Inc

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aclarion Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker ACON. The last closing price for Aclarion was $0.29. Over the last year, Aclarion shares have traded in a share price range of $ 0.2668 to $ 11.504.

Aclarion currently has 8,203,500 shares outstanding. The market capitalization of Aclarion is $2.38 million. Aclarion has a price to earnings ratio (PE ratio) of -0.48.

ACON Latest News

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Aviva is a Top 4 Provider of Private Medical Insurance in the UK By Joining AXA, Approximately 45% of Patients With Private Insurance Now Have Access to Nociscan in the Greater London Spine Care...

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

AXA is the 2nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume and Revenue AXA Represents the First...

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Established in 1932, the London Clinic is the UK’s Most Renowned Independent, Private Hospital Payment to Aclarion for Each Nociscan is Being Increased From the Original Contract Contract...

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer national health insurance system...

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

Confirms predictive value of Nociscan for identifying painful discs. Nociscan demonstrated a sensitivity of 100% and a specificity of 80% compared to provocative discography (PD), suggesting...

Aclarion Announces Closing of $3.0 Million Public Offering

BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0134-4.2880.31250.320.28541613980.29552264CS
40.01013.494809688580.2890.320.26794888650.2957645CS
12-0.0261-8.02583025830.32520.370.26796069910.30669201CS
26-2.7709-90.25732899023.073.850.266819318260.76958619CS
52-9.7969-97.037440570510.09611.5040.266814497182.12155312CS
156-46.1009-99.35538793146.464.80.2668110950710.86515848CS
260-46.1009-99.35538793146.464.80.2668110950710.86515848CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HUBCWHub Cyber Security Ltd
$ 0.0345
(94.92%)
62
SERVServe Robotics Inc
$ 4.77
(81.37%)
4.95M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3317
(34.84%)
6.87M
GNLXGenelux Corporation
$ 2.90
(26.09%)
2
CXAICXApp Inc
$ 2.80
(25.56%)
647
KITTNauticus Robotics Inc
$ 0.102
(-20.87%)
994.18k
SPWRSunPower Corporation
$ 1.24
(-17.88%)
674.53k
MTEMMolecular Templates Inc
$ 1.21
(-15.38%)
1
AZA2Z Smart Technologies Corporation
$ 0.7623
(-14.33%)
173
GDTCCytoMed Therapeutics Ltd
$ 1.97
(-13.98%)
246
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3317
(34.84%)
6.87M
SGDSafe and Green Development Corporation
$ 0.4165
(12.63%)
6.12M
SERVServe Robotics Inc
$ 4.77
(81.37%)
4.95M
SQQQProShares UltraPro Short QQQ
$ 8.19
(-0.49%)
3.3M
MAXNMaxeon Solar Technologies Ltd
$ 0.2298
(-4.41%)
2.64M

ACON Discussion

View Posts
mining101 mining101 1 week ago
When mooning?
👍️0
stock1ace1 stock1ace1 2 months ago
50ma/20ma cross
👍️0
mining101 mining101 2 months ago
Big volume guided the way a few weeks ago
👍️0
Termite7 Termite7 2 months ago
How high of a moon? ....Thanks!!!
👍️0
mining101 mining101 2 months ago
Moon soon
👍️0
Awl416 Awl416 3 months ago
Knock knock… who’s there?
👍️0
luckydude777 luckydude777 4 months ago
Picked up a popcorn bag full earlier at $.328 just for the heck of it.
👍️0
gail gail 4 months ago
grabbed some post market. runs like hell in the past. we shall see.
👍️0
DK11 DK11 4 months ago
Hang on Invest, I am sure you're Bull is coming Lol
👍️0
Invest-in-America Invest-in-America 4 months ago
ACON: "But don't tell my heart, my ACON breaky heart
I just don't think he'd understand;
And if you tell my heart, my ACON breaky heart
He might blow up and kill this man!!"


(Mr. Billy, & his CHARMING Daughter!!!)
👍️0
luckydude777 luckydude777 4 months ago
Company used some of it's pocket change to run the price up over $.09 earlier so they could dump a gazillion under $.08. Hummmmm ....

Seems like a PR (no matter how hokey it might be) would have been a better strategy.

Something to the effect: "We have discovered what we believe to be a revolutionary way to keep our patients from pooping while being given certain treatments. We'll be looking to file a patent on this amazing discovery just as soon as we can raise enough cash to pay for the initial patent fee."
👍️0
luckydude777 luckydude777 4 months ago
NOW we're starting to talk! YEAH BABY!
👍️0
luckydude777 luckydude777 4 months ago
Love these dumping prices. MORE!!!
👍️0
luckydude777 luckydude777 4 months ago
Got some at $.4099 a bit ago. Good price IMO.
👍️0
INFINITI INFINITI 5 months ago
It’s super thin slap that ask
👍️0
INFINITI INFINITI 5 months ago
Yes I saw that
👍️0
ncstrongman ncstrongman 5 months ago
Just announced, CLOSED
👍️0
INFINITI INFINITI 5 months ago
Aclarion Announces Closing of $3.0 Million Public Offering

Source: GlobeNewswire Inc.

via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced the closing of its public offering of 5,175,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant in lieu thereof), and two common warrants, with each common warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.58. The common warrants are immediately exercisable at a price of $0.58 per share and expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants were only purchasable together in this offering, but were issued separately and immediately separable upon issuance.
Gross proceeds, before deducting placement agent fees and other offering expenses, are approximately $3.0 million.

Maxim Group LLC acted as sole placement agent in connection with this offering.

The securities described above were offered pursuant to a registration statement on Form S-1, as amended (File No. 333-275989) (the “Registration Statement”), which was declared effective by the Securities and Exchange Commission (the "SEC") on February 26, 2024. The offering was made only by means of a prospectus which is a part of the Registration Statement. A copy of the final prospectus relating to the offering has been filed with the SEC and may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, at (212) 895-3745.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Aclarion, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company’s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as “anticipates,” “believes” and “expects” or similar expressions, are forward-looking statements.

All of our forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled “Risk Factors” in the Registration Statement, as well as other disclosures contained in such Registration Statement and the Company’s other filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com

Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com

👍️0
INFINITI INFINITI 5 months ago
Closing tomorrow it should go back up
👍️ 1
Sly1969 Sly1969 5 months ago
Sold at 71 cents premarket today after buying at 60 cents and loaded back up under 32 cents on bigger dip. Hope to sell at 50 cents or above
👍️0
Sly1969 Sly1969 5 months ago
Sold at 71 cents premarket today after buying at 60 cents and loaded back up under 32 cents on bigger dip. Hope to sell at 50 cents or above
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
Sly1969 Sly1969 5 months ago
Rentry today on dip premarket.. 0.6093 average
👍️0
cottonmather cottonmather 5 months ago
ACON has no technical synchronicity except on the short end. $1 is often a pit stop but that point is showing no favor either. It's on my watchlist but nothing more. https://schrts.co/CYDkRKKW
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
Monksdream Monksdream 5 months ago
ACON new 52/week low
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
Monksdream Monksdream 5 months ago
ACON new 52 week low
👍️0
subslover subslover 6 months ago
And here it goes again up 100%
👍️0
Monksdream Monksdream 6 months ago
ACON new 52 week low
👍️0
TheFinalCD TheFinalCD 6 months ago
HERES WHY
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173581186
👍️0
madras50 madras50 6 months ago
well that didn't last.
👍️0
TheFinalCD TheFinalCD 6 months ago
6.81 Damn
Message in reply to:
👍️0
Monksdream Monksdream 6 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
TheFinalCD TheFinalCD 6 months ago
ACON FLYING ON NEWS: https://www.globenewswire.com/news-release/2024/01/08/2805404/0/en/Aclarion-and-ATEC-Execute-Strategic-Partnership-Agreement-to-Advance-Commercialization-of-Nociscan.html



BUT ANOTHER HIGH RISK LOW CASH RUNNER CYCC SPEC
Overall Risk
High
Offering Ability
High
Overhead Supply
High
Historical
High
Cash Need
High
https://dilutiontracker.com/app/search/ACON?a=dbb88c
👍️0
Awl416 Awl416 6 months ago
Again
👍️0
Awl416 Awl416 6 months ago
Damn
👍️0
Monksdream Monksdream 6 months ago
ACON new 52 week low
👍️0
TheFinalCD TheFinalCD 6 months ago
problem for many is they dont realize only a few brokers have the new shares ready for trade in their accounts


I dont mess with any corporate actions that cause share settlement through the TA

one time I had shares in TDA, was too new and dumb to know the stock was even splitting, then when it split it ran up I was excited because I was up around $10,000...BUT

TDA didnt have the split-adjusted shares in my account for over a week

by the time they did I was -down money

ETRADE was one of the only brokers that fronted customer shares before they were even settled by the TA
👍️0
wickerman wickerman 6 months ago
$ACON here come the discord pumpers thinking everyone will rush in and buy their bid up shares tomorrow...funny.
👍️0
heyitsmeagain heyitsmeagain 6 months ago
🔥🔥
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 7 months ago
$ACON
https://x.com/hannahadad8890/status/1737607889089601699?s=61
👍️0
cottonmather cottonmather 7 months ago
It better be. I waited for the drop to below the 50ma to get in. So far, I'm smart
👍️0
INFINITI INFINITI 7 months ago
Bottoms in
👍️0
cottonmather cottonmather 7 months ago
I'm on. Had to wait fer the drop
👍️0
TheFinalCD TheFinalCD 7 months ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172091953
👍️0
Invest-in-America Invest-in-America 7 months ago
ACON: O.K., now I get it!!! (Their MR gadgets can help Doctors determine WHICH ONE of the patient's many Spinal Discs is causing the PAIN that the patient is experiencing.)
https://aclarion.com/
///////////////////////////////////////////////////////////////
👍️ 1

Your Recent History

Delayed Upgrade Clock